Redwood Scientific (OTC: RSCI) Teams Up with Jeeva Clinical Study” Aimed at “Smoking and E-cigarette Cessation

The pharmaceutical industry stands out as a hub of innovation, attracting investors seeking standout companies. Redwood Scientific Technologies Inc. (OTC: RSCI), headquartered in New York, has been pioneering groundbreaking work in this sector. On February 6, 2023, the company unveiled a significant development: an agreement with Jeeva Clinical Trials. 

Under the terms of the agreement, the two firms would work together on initiating a clinical efficacy examination of Redwood Scientific Technologies’ TBX-Free oral strip offerings designed to aid in quitting smoking and e-cigarette usage. Furthermore, it was highlighted that Redwood had enlisted the expertise of George Mason University, a leading academic institution in the United States, to oversee the effectiveness evaluation of its novel product. 

Jason Cardiff, the CEO of the organization, addressed the recent advancements, emphasizing Redwood Scientific Technologies’ dedication to crafting safe and efficient solutions to aid countless individuals in breaking free from nicotine dependency. Cardiff expressed confidence that partnering with esteemed institutions would facilitate this goal. He underscored the company’s acknowledgment of the burgeoning crisis, affirming management’s commitment to expeditiously introducing the product to market. 

In this context, it’s crucial to recognize nicotine as one of the most addictive substances globally, functioning as both a sedative and a stimulant. According to reports, over 8 million adults in the United States utilize e-cigarettes, with over 28.3 million smoking traditional cigarettes. Even more concerning is the revelation that over 16.5% of high school students engage in tobacco use. 

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Posted

in

by

Tags: